In September 2022, Singmed has completed the A round of financing, with exclusive investment from Creacion Ventures. This is our first external financing since its establishment. The funds will be used for the construction of the company’s pulmonary drug and nasal drug delivery technology platforms and world class medical grade manufacturing facility and expand the team.

Creacion Ventures is a multinational venture capital dollar fund company established in Boston, USA and Shanghai, China, focusing on early-stage investments in the fields of biomedicine and medical devices, and exploring industrial opportunities driven by innovation in the life sciences and health industries. It is particularly focused on creating an incubation platform company in China and the United States, with extensive experience in supporting biomedical technology startups.